<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="762b51be-1893-4cd1-9511-e645fc420d3a"><labelDrug name="INOmax"><Normalization><mmtx cui="C1330345" preferredWord="INOmax" semType="inch, phsu"/></Normalization></labelDrug><generic name="nitric oxide"/><sentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.1" text="INOMAX (nitric oxide) gas" type="negative"><entity charOffset="8:25" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.1.e.0" text="nitric oxide gas" type="Biomedical_Entity"><Normalization><mmtx cui="C0028128" phraseText="(nitric oxide) gas" preferredWord="Nitric Oxide" semType="bacs, inch, phsu"/><RxNorm RxCui="1311391"/></Normalization></entity><entity charOffset="0:6" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.1.e.1" text="inomax" type="Biomedical_Entity"><Normalization><mmtx cui="C1330345" phraseText="INOMAX" preferredWord="INOmax" semType="inch, phsu"/><RxNorm RxCui="405139"/></Normalization></entity><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.1.e.1" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.1.e.0"/></sentence><sentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.2" text="INOmax (nitric oxide gas) is a drug administered by inhalation. " type="negative"><entity charOffset="0:6" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.2.e.0" text="inomax" type="Biomedical_Entity"><Normalization><mmtx cui="C1330345" phraseText="INOmax" preferredWord="INOmax" semType="inch, phsu"/><RxNorm RxCui="405139"/></Normalization></entity><entity charOffset="8:24" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.2.e.1" text="nitric oxide gas" type="Biomedical_Entity"><Normalization><mmtx cui="C0028128" phraseText="(nitric oxide gas" preferredWord="Nitric Oxide" semType="bacs, inch, phsu"/><RxNorm RxCui="1311391"/></Normalization></entity><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.2.e.0" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.2.e.1"/></sentence><sentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3" text="Nitric oxide, the active substance in INOmax, is a pulmonary vasodilator." type="negative"><entity charOffset="0:12" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.0" text="nitric oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0028128" phraseText="Nitric oxide," preferredWord="Nitric Oxide" semType="bacs, inch, phsu"/><RxNorm RxCui="1311391"/></Normalization></entity><entity charOffset="61:72" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.1" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="a pulmonary vasodilator." preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="38:44" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.2" text="inomax" type="Biomedical_Entity"><Normalization><mmtx cui="C1330345" phraseText="the active substance in INOmax," preferredWord="INOmax" semType="inch, phsu"/><RxNorm RxCui="405139"/></Normalization></entity><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.0" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.1"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.0" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.2"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.2" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.3.e.1"/></sentence><sentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.18" text="Patients who had pre-existing left ventricular dysfunction treated with inhaled nitric oxide, even for short durations, experienced serious adverse events (e.g., pulmonary edema)." type="negative"><entity charOffset="109:118" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.18.e.0" text="durations" type="Biomedical_Entity"><Normalization><mmtx cui="C2926735" phraseText="even for short durations," preferredWord="Duration" semType="phsu"/><RxNorm RxCui="1001007"/></Normalization></entity><entity charOffset="80:92" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.18.e.1" text="nitric oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0028128" phraseText="treated with inhaled nitric oxide," preferredWord="Nitric Oxide" semType="bacs, inch, phsu"/><RxNorm RxCui="1311391"/></Normalization></entity><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.18.e.1" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.18.e.0"/></sentence><sentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21" text="INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation. " type="negative"><entity charOffset="56:66" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.0" text="dobutamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0012963" phraseText="dobutamine," preferredWord="Dobutamine" semType="phsu, orch"/><RxNorm RxCui="203121"/></Normalization></entity><entity charOffset="34:44" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.1" text="tolazoline" type="Biomedical_Entity"><Normalization><mmtx cui="C0040373" phraseText="administered with tolazoline," preferredWord="Tolazoline" semType="phsu, orch"/><RxNorm RxCui="235450"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.2" text="surfactant" type="Biomedical_Entity"><Normalization><mmtx cui="C0034085" phraseText="surfactant," preferredWord="Pulmonary Surfactants" semType="bacs, phsu, lipd"/><RxNorm RxCui="1437041"/></Normalization></entity><entity charOffset="0:6" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.3" text="inomax" type="Biomedical_Entity"><Normalization><mmtx cui="C1330345" phraseText="INOmax" preferredWord="INOmax" semType="inch, phsu"/><RxNorm RxCui="405139"/></Normalization></entity><entity charOffset="46:54" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.4" text="dopamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0013030" phraseText="dopamine," preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.1" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.0"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.0" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.2"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.3" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.0"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.4" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.0"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.1" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.2"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.3" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.1"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.1" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.4"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.3" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.2"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.4" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.2"/><pair ddi="false" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.3" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.21.e.4"/></sentence><sentence biomedicalEntities="4" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22" lineNumber="29" text="Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia. " type="regular"><entity charOffset="62:90" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.0" text="nitric oxide donor compounds" type="Drug_Class"><Normalization><mmtx cui="C0600437" phraseText="nitric oxide donor compounds," preferredWord="Nitric Oxide Donors" semType="phsu"/><mmtx cui="C1706082" phraseText="nitric oxide donor compounds," preferredWord="Compound (substance)" semType="chem"/><RxNorm RxCui="1311391"/></Normalization></entity><entity charOffset="102:122" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.1" text="sodium nitroprusside" type="Drug"><Normalization><mmtx cui="C0037533" phraseText="sodium nitroprusside" preferredWord="Sodium Nitroprusside" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="127:140" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.2" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="nitroglycerin," preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="nitroglycerin," preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="175:181" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.5" text="INOmax" type="Drug"><Normalization><mmtx cui="C1330345" phraseText="an additive effect with INOmax" preferredWord="INOmax" semType="inch, phsu"/><RxNorm RxCui="405139"/></Normalization></entity><entity charOffset="208:225" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.6" text="methemoglobinemia" type="Specific_Interaction"><Normalization><mmtx cui="C0025637" phraseText="of developing methemoglobinemia." preferredWord="Methemoglobinemia" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.1" drugClass="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.0"/><drugClassMembership drug="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.2" drugClass="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.0"/><drugInteraction id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.ddi.1"><interaction trigger="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.0" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.5" trigger="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23" lineNumber="29" text="An association between prilocaine and an increased risk of methemoglobinemia, particularly in infants, has specifically been described in a literature case report. " type="irregular"><entity charOffset="23:33" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.0" text="prilocaine" type="Drug"><Normalization><mmtx cui="C0033124" phraseText="An association between prilocaine" preferredWord="Prilocaine" semType="phsu, orch"/><RxNorm RxCui="8686"/></Normalization></entity><entity charOffset="59:76" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.1" text="methemoglobinemia" type="Specific_Interaction"><Normalization><mmtx cui="C0271905" phraseText="an increased risk of methemoglobinemia," preferredWord="Acquired methemoglobinemia" semType="dsyn"/></Normalization></entity><entity charOffset="94:101" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.3" text="infants" type="SPAN"/><entity charOffset="151:162" id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.4" text="case report" type="SPAN"/><drugInteraction id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.ddi.1"><interaction trigger="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22" text="Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia. "><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.22.e.5"/></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.762b51be-1893-4cd1-9511-e645fc420d3a.s.23.e.0"/></sentence><positiveExamples number="2"/><negativeExamples number="16"/></document>